Literature DB >> 33399906

Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex.

Giorgio Conte1, Valeria Elisa Contarino1, Silvia Casale2, Claudia Morelli3, Sara Sbaraini4, Elisa Scola1, Francesca Trogu3,5, Silvia Siggillino1, Claudia Maria Cinnante1, Luca Caschera1, Francesco Maria Lo Russo1, Fabio Maria Triulzi1,5, Vincenzo Silani3,5.   

Abstract

OBJECTIVES: The aim of our study was to investigate whether the magnetic susceptibility varies according to the amyotrophic lateral sclerosis (ALS) phenotypes based on the predominance of upper motor neuron (UMN)/lower motor neuron (LMN) impairment.
METHODS: We retrospectively collected imaging and clinical data of 47 ALS patients (12 with UMN predominance (UMN-ALS), 16 with LMN predominance (LMN-ALS), and 19 with no clinically defined predominance (Np-ALS)). We further enrolled 23 healthy controls (HC) and 15 ALS mimics (ALS-Mim). These participants underwent brain 3-T magnetic resonance imaging (3-T MRI) with T1-weighted and gradient-echo multi-echo sequences. Automatic segmentation and quantitative susceptibility mapping (QSM) were performed. The skewness of the susceptibility values in the precentral cortex (SuscSKEW) was automatically computed, compared among the groups, and correlated to the clinical variables.
RESULTS: The Kruskal-Wallis test showed significant differences in terms of SuscSKEW among groups (χ2(3) = 24.2, p < 0.001), and pairwise tests showed that SuscSKEW was higher in UMN-ALS compared to those in LMN-ALS (p < 0.001), HC (p < 0.001), Np-ALS (p = 0.012), and ALS-Mim (p < 0.001). SuscSKEW was highly correlated with the Penn UMN score (Spearman's rho 0.612, p < 0.001).
CONCLUSION: This study demonstrates that the clinical ALS phenotypes based on UMN/LMN sign predominance significantly differ in terms of magnetic susceptibility properties of the precentral cortex. Combined MRI-histopathology investigations are strongly encouraged to confirm whether this evidence is due to iron overload in UMN-ALS, unlike in LMN-ALS. KEY POINTS: • Magnetic susceptibility in the precentral cortex reflects the prevalence of UMN/LMN impairment in the clinical ALS phenotypes. • The degree of UMN/LMN impairment might be well described by the automatically derived measure of SuscSKEW in the precentral cortex. • Increased SuscSKEW in the precentral cortex is more relevant in UMN-ALS patients compared to those in Np-ALS and LMN-ALS patients.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Magnetic resonance imaging; Motor cortex; Motor neuron disease

Year:  2021        PMID: 33399906     DOI: 10.1007/s00330-020-07547-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  17 in total

1.  Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis.

Authors:  Juan F Vázquez-Costa; Miguel Mazón; Joan Carreres-Polo; David Hervás; Jordi Pérez-Tur; Luis Martí-Bonmatí; Teresa Sevilla
Journal:  Acta Neurol Scand       Date:  2017-10-29       Impact factor: 3.209

2.  Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis.

Authors:  Andrew D Schweitzer; Tian Liu; Ajay Gupta; Karen Zheng; Stephen Seedial; Alexander Shtilbans; Mona Shahbazi; Dale Lange; Yi Wang; A John Tsiouris
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

3.  Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.

Authors:  Felix Geser; Beth Stein; Michael Partain; Lauren B Elman; Leo F McCluskey; Sharon X Xie; Vivianna M Van Deerlin; Linda K Kwong; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2011-01-12       Impact factor: 17.088

4.  A revision of the El Escorial criteria - 2015.

Authors:  Albert Ludolph; Vivian Drory; Orla Hardiman; Imaharu Nakano; John Ravits; Wim Robberecht; Jeremy Shefner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-06-29       Impact factor: 4.092

5.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

Review 6.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

7.  Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex.

Authors:  Valeria Elisa Contarino; Giorgio Conte; Claudia Morelli; Francesca Trogu; Elisa Scola; Sonia Francesca Calloni; Luis Carlos Sanmiguel Serpa; Chunlei Liu; Vincenzo Silani; Fabio Triulzi
Journal:  Eur J Radiol       Date:  2020-01-11       Impact factor: 3.528

8.  Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.

Authors:  Justin Y Kwan; Suh Young Jeong; Peter Van Gelderen; Han-Xiang Deng; Martha M Quezado; Laura E Danielian; John A Butman; Lingye Chen; Elham Bayat; James Russell; Teepu Siddique; Jeff H Duyn; Tracey A Rouault; Mary Kay Floeter
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis.

Authors:  M Costagli; G Donatelli; L Biagi; E Caldarazzo Ienco; G Siciliano; M Tosetti; M Cosottini
Journal:  Neuroimage Clin       Date:  2016-05-02       Impact factor: 4.881

Review 10.  Mimics and chameleons in motor neurone disease.

Authors:  Martin R Turner; Kevin Talbot
Journal:  Pract Neurol       Date:  2013-04-24
View more
  3 in total

1.  Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis!

Authors:  Eleonora Giacopuzzi Grigoli; Claudia Cinnante; Pietro Emiliano Doneddu; Narghes Calcagno; Sveva Lenti; Andrea Ciammola; Luca Maderna; Nicola Ticozzi; Massimo Castellani; Sandro Beretta; Marco Rovaris; Vincenzo Silani; Federico Verde
Journal:  Neurol Sci       Date:  2022-09-19       Impact factor: 3.830

Review 2.  Feature selection from magnetic resonance imaging data in ALS: a systematic review.

Authors:  Thomas D Kocar; Hans-Peter Müller; Albert C Ludolph; Jan Kassubek
Journal:  Ther Adv Chronic Dis       Date:  2021-10-13       Impact factor: 5.091

3.  Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases.

Authors:  Antonietta Canna; Francesca Trojsi; Federica Di Nardo; Giuseppina Caiazzo; Gioacchino Tedeschi; Mario Cirillo; Fabrizio Esposito
Journal:  Ann Clin Transl Neurol       Date:  2021-08-02       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.